The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways.

doi:10.1210/endo.138.10.5432

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways.

Endocrinology - 1 Oct 1997

Thibonnier M, Preston J A, Dulin N, Wilkins P L, Berti-Mattera L N, Mattera R

Abstract excerpt

The vasopressin (AVP) V3 pituitary receptor (V3R) is a G protein-coupled corticotropic phenotypic marker that is overexpressed in ACTH-hypersecreting tumors. Studies of the agonist/antagonist binding profile and signal transduction pathways linked to the human V3R have been limited because of the...

Topics

Animals
Arachidonic Acid
Base Sequence
CHO Cells
Calcium-Calmodulin-Dependent Protein Kinases
Cell Division
Cricetinae
Cyclic AMP
DNA
Dose-Response Relationship, Drug
Female
Humans

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Ligands

Pertussis Toxin

Phenotype

Phosphorylation

Pituitary Gland

Protein Binding

Source

Open in PubMed

Identifiers

PMID: 9322919
DOI: 10.1210/endo.138.10.5432

Genes

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-9322919-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways.PMID 9322919Read ↗

V3 vasopressin receptor and corticotropic phenotype in pituitary and nonpituitary tumors.Semantic proximity Read ↗

Vasopressin receptors modulate the pharmacological phenotypes of Cushing's syndrome.Semantic proximity Read ↗

The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.Semantic proximity Read ↗

Overexpression of vasopressin (V3) and corticotrophin‐releasing hormone receptor genes in corticotroph tumoursSemantic proximity Read ↗

Two vasopressin type 2 receptor gene mutations R143P and delta V278 in patients with nephrogenic diabetes insipidus impair ligand binding of the receptor.Semantic proximity Read ↗

Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.Semantic proximity Read ↗

Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone.Semantic proximity Read ↗

Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.Semantic proximity Read ↗

Differential signaling and immediate-early gene activation by four splice variants of the human pituitary adenylate cyclase-activating polypeptide receptor (hPACAP-R).Semantic proximity Read ↗

Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors.Semantic proximity Read ↗

Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U‐937 cellsSemantic proximity Read ↗

Molecular Identification and Analysis of a Novel Human Corticotropin-Releasing Factor (CRF) Receptor: The CRF2γ ReceptorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.